Regulatory & Industry News
FDA panels, compounding rules and other regulatory developments affecting research supply.
This topic follows the rules that shape what research suppliers can legally sell and ship: FDA advisory panel votes, pharmacy compounding decisions, import enforcement and state-level policy. Regulatory change reaches a bench faster than most people expect, and when a compound moves between categories the practical consequence is rarely stated plainly anywhere. The articles here translate those moves into what actually changes for the person placing a research order: what stays available, how the documentation changes shape, and which suppliers adjust first. Everything in this section is written for laboratory reference only, not as legal advice.
1 article in this topic. For research and educational reference only.
